Italy

MITO

Multicenter Italian Trials in Ovarian Cancer

Ongoing Trials:
- MITO-8/ENGOT-ov-I : Pegylated liposomal doxorubicin versus carboplatin/paclitaxel in patients ovarian cancer recurrence between six and twelve months after prvious platinum based chemotherapy.

- MITO-7 : first-line weekly carboplatin and paclitaxel versus 3 weekly carboplatin/paclitaxel in patients with ovarian cancer.

- Collaborative nursing study : Pathway to diagnose ovarian cancer in Italian women : an exploratory study.

- Cervical cancer, carboplatin/ taxoplatin/ cetuximab.

	Download the Summary of ongoing project^*

	Visit the Offical Website

• Back

^* If you are unable to view PDF files, please download a free PDF Reader from Adobe's website.